TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Not Specified
Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Direct Meds, a LegitScript-certified telehealth platform, continues facilitating access to compounded semaglutide and tirzepatide through licensed providers as the weight loss medication market experiences regulatory changes. The platform operates with independent healthcare providers and 503A compounding pharmacies, though compounded medications remain non-FDA-approved and carry serious safety risks including potential thyroid C-cell tumors.

Insights
BACpQ   neutral

Buffett trimmed the position by 26.3 million shares, suggesting a measured approach to the financial sector


NVO   neutral

Mentioned only as the manufacturer of FDA-approved Ozempic and Wegovy. The article notes that Direct Meds is not affiliated with or endorsed by Novo Nordisk. The mention is contextual rather than substantive to the main narrative.